In our experimental group treated with AOM/DSS there was an increase of IL-10 concentration and this would represent an unfavorable prognostic factor for mice with cancer; however if we consider all the damage to the intestinal mucosa by the administration of DSS, IL-10 can increase its concentration, because it is playing a role of immunological tolerance. The gene discussed is IL10; the disease is cancer.